Medtronic Cardiovascular
Clinical trials sponsored by Medtronic Cardiovascular, explained in plain language.
-
Second chance for failing heart valves: new study tests repeat TAVR
Disease control Recruiting nowThis study is for people with aortic stenosis whose first transcatheter heart valve has failed and needs to be replaced. Researchers want to see if a second, minimally invasive valve replacement (redo TAVR) is safe and works well. About 225 participants will be followed for one y…
Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New valve replacement could fix leaky heart without opening chest
Disease control Recruiting nowThis study tests a new device that replaces a leaky tricuspid heart valve using a tube inserted through a leg vein, avoiding open-heart surgery. It includes 150 people with severe valve leakage who are still having symptoms despite medication. The goal is to see if the device is …
Phase: NA • Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated May 13, 2026 16:01 UTC